Vext Science, Inc.
VEXT
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.99M | 8.43M | 8.39M | 8.42M | 8.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.99M | 8.43M | 8.39M | 8.42M | 8.10M |
| Cost of Revenue | 5.02M | 6.87M | 7.06M | 6.55M | 5.29M |
| Gross Profit | 3.97M | 1.55M | 1.33M | 1.87M | 2.80M |
| SG&A Expenses | 3.01M | 3.01M | 2.57M | 7.49M | 2.70M |
| Depreciation & Amortization | 2.25M | 2.30M | 2.00M | 2.03M | 1.83M |
| Other Operating Expenses | -- | -- | -- | -1.00K | -6.00K |
| Total Operating Expenses | 10.28M | 12.19M | 11.63M | 16.07M | 9.82M |
| Operating Income | -1.29M | -3.76M | -3.24M | -7.66M | -1.72M |
| Income Before Tax | -2.74M | -4.52M | -6.67M | 7.94M | -2.90M |
| Income Tax Expenses | -238.80K | -127.20K | -340.50K | 2.31M | -1.06M |
| Earnings from Continuing Operations | -2.50M | -4.39M | -6.33M | 5.63M | -1.84M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.50M | -4.39M | -6.33M | 5.63M | -1.84M |
| EBIT | -1.29M | -3.76M | -3.24M | -7.66M | -1.72M |
| EBITDA | 2.35M | -50.90K | 197.40K | -4.20M | 634.00K |
| EPS Basic | -0.01 | -0.02 | -0.03 | 0.03 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.02 | -0.03 | 0.03 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 245.55M | 245.45M | 225.13M | 209.13M | 149.77M |
| Average Diluted Shares Outstanding | 248.66M | 245.45M | 225.36M | 209.40M | 149.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
